Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis

Submitted: 7 December 2014
Accepted: 22 January 2015
Published: 5 October 2015
Abstract Views: 1156
PDF: 787
HTML: 385
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We herein describe the case of a 65-year-old man with frequent hospitalizations for severe anemia due to several recurrent bleedings of a cutaneous metastasis of hepatocellular carcinoma, and its successful off label treatment with thalidomide therapy for controlling bleeding and reducing transfusion requirements.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

How to Cite

Silvestri, F., Da Porto, A., Labombarda, A., Mansutti, E., & Rogato, A. (2015). Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis. Italian Journal of Medicine, 9(4), 377–379. https://doi.org/10.4081/itjm.2015.570